[go: up one dir, main page]

WO2008007391A3 - An improved process for the preparation of valsartan - Google Patents

An improved process for the preparation of valsartan Download PDF

Info

Publication number
WO2008007391A3
WO2008007391A3 PCT/IN2007/000279 IN2007000279W WO2008007391A3 WO 2008007391 A3 WO2008007391 A3 WO 2008007391A3 IN 2007000279 W IN2007000279 W IN 2007000279W WO 2008007391 A3 WO2008007391 A3 WO 2008007391A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
valsartan
improved process
relates
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IN2007/000279
Other languages
French (fr)
Other versions
WO2008007391A2 (en
Inventor
Manne Satyanarayana Reddy
Muppa Kishore Kumar
Karamala Rama Subba Reddy
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of WO2008007391A2 publication Critical patent/WO2008007391A2/en
Anticipated expiration legal-status Critical
Publication of WO2008007391A3 publication Critical patent/WO2008007391A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to an improved process for the preparation of valsartan compound of formula-1 through novel intermediate compounds. It also relates to a novel process for the preparation of amorphous form of valsartan.
PCT/IN2007/000279 2006-07-10 2007-07-09 An improved process for the preparation of valsartan Ceased WO2008007391A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN1204/CHE/2006 2006-07-10
IN1204CH2006 2006-07-10

Publications (2)

Publication Number Publication Date
WO2008007391A2 WO2008007391A2 (en) 2008-01-17
WO2008007391A3 true WO2008007391A3 (en) 2010-02-18

Family

ID=38923685

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IN2007/000279 Ceased WO2008007391A2 (en) 2006-07-10 2007-07-09 An improved process for the preparation of valsartan

Country Status (1)

Country Link
WO (1) WO2008007391A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2260018A2 (en) 2008-04-07 2010-12-15 Hetero Research Foundation Process for preparation of valsartan intermediate
WO2012056294A1 (en) 2010-10-29 2012-05-03 Jubilant Life Sciences Ltd. An improved process for the preparation of n-pentanoyl-n-[[2'-(1h-tetrazol-5-yi)[1,1'-biphenyl]-4-yi]methyl]-l-valine
CN102702118B (en) * 2012-06-11 2014-04-16 吉林三善恩科技开发有限公司 Valsartan organic pharmaceutical co-crystal and preparation method thereof
CN104072433A (en) * 2014-07-16 2014-10-01 南京正大天晴制药有限公司 Hydrolysable impurity compound of valsartan and preparation method, detection method and use thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004094391A2 (en) * 2003-04-21 2004-11-04 Teva Pharmaceutical Industries Ltd. Process for the preparation of valsartan and intermediates thereof
WO2005102987A1 (en) * 2004-04-20 2005-11-03 Inke, S.A. Process for the preparation of valsartan and precursors thereof
EP1661891A1 (en) * 2004-11-30 2006-05-31 KRKA, D.D., Novo Mesto A process for the synthesis of valsartan

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004094391A2 (en) * 2003-04-21 2004-11-04 Teva Pharmaceutical Industries Ltd. Process for the preparation of valsartan and intermediates thereof
WO2005102987A1 (en) * 2004-04-20 2005-11-03 Inke, S.A. Process for the preparation of valsartan and precursors thereof
EP1661891A1 (en) * 2004-11-30 2006-05-31 KRKA, D.D., Novo Mesto A process for the synthesis of valsartan

Also Published As

Publication number Publication date
WO2008007391A2 (en) 2008-01-17

Similar Documents

Publication Publication Date Title
EP2460797A3 (en) Process for preparation of ivabradine hydrochloride
WO2008155615A3 (en) An improved process for the preparation of cephalosporin antibiotic
WO2009036281A3 (en) Bortezomib and process for producing same
WO2009076142A3 (en) Processes for producing cycloalkylcarboxiamido-pyridine benzoic acids
WO2010062590A3 (en) Process for the preparation of protected l-alanine derivatives
WO2009095933A3 (en) Improved and novel process for the preparation of bosentan
WO2009068463A9 (en) Process for the preparation of isoindole derivatives as well as a process for the preparation of their intermediates
WO2010014666A3 (en) Processes and intermediates for making sweet taste enhancers
WO2010015657A3 (en) Alkoxypyrazoles and the process for their preparation
WO2010036329A3 (en) Process for making quinolone compounds
WO2008053334A3 (en) An improved process for preparing rosuvastatin calcium
WO2011024192A3 (en) Novel polymorphs of raltegravir
WO2011015287A3 (en) Process for the preparation of derivatives of 1-(2-halobiphenyl-4-yl)-cyclopropanecarboxylic acid
WO2008075205A3 (en) Improved process for the preparation of voriconazole
WO2010004578A3 (en) Novel and improved processes for the preparation of paliperidone
WO2010015656A3 (en) Alkoxypyrazoles and the process for their preparation
WO2008033757A3 (en) 2-(1-oxo-1h-isoquinolin-2-yl) acetamide derivatives
WO2007099552A3 (en) Novel crystalline form of atovastatin hemi-magnesium
WO2008007391A3 (en) An improved process for the preparation of valsartan
WO2008035360A3 (en) Novel crystalline forms of candesartan cilexetil, candesartan, tritylated candesartan and tritylated candesartan cilexetil
IL186294A0 (en) A process for the preparation of phenyltetrazole compounds
WO2009060297A3 (en) An improved process for the preparation of paliperidone and its intermediates
WO2006075139A3 (en) Novel process for the preparation of substituted indoles
WO2007096903A3 (en) New crystalline form of atorvastatin hemi-calcium
TW200637832A (en) Process for preparing amorphous valsartan

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07827513

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

122 Ep: pct application non-entry in european phase

Ref document number: 07827513

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)